首页> 外文期刊>Cancer Cell >Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
【24h】

Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells

机译:巨噬细胞IL-10通过抑制肿瘤内树突状细胞中IL-12的表达来阻断CD8 + T细胞依赖化学疗法的反应。

获取原文
获取原文并翻译 | 示例
       

摘要

Blockade of colony-stimulating factor-1 (CSF-1) limits macrophage infiltration and improves response of mammary carcinomas to chemotherapy. Herein we identify interleukin (IL)-10 expression by macrophages as the critical mediator of this phenotype. Infiltrating macrophages were the primary source of IL-10 within tumors, and therapeutic blockade of IL-10 receptor (IL-10R) was equivalent to CSF-1 neutralization in enhancing primary tumor response to paclitaxel and carboplatin. Improved response to chemotherapy was CD8+ Tcell-dependent, but IL-10 did not directly suppress CD8+ Tcells or alter macrophage polarization. Instead, IL-10R blockade increased intratumoral dendritic cell expression of IL-12, which was necessary for improved outcomes. In human breast cancer, expression of IL12A and cytotoxic effector molecules were predictive of pathological complete response rates to paclitaxel.
机译:阻断集落刺激因子1(CSF-1)限制了巨噬细胞的浸润并改善了乳腺癌对化学疗法的反应。在本文中,我们通过巨噬细胞鉴定白介素(IL)-10表达作为该表型的关键介体。浸润性巨噬细胞是肿瘤内IL-10的主要来源,IL-10受体(IL-10R)的治疗性阻断作用相当于CSF-1中和作用,可增强对紫杉醇和卡铂的原发性肿瘤反应。对化疗的改善反应是CD8 + T细胞依赖性的,但IL-10不能直接抑制CD8 + Tcell或改变巨噬细胞极化。相反,IL-10R阻断可增加肿瘤内树突状细胞表达IL-12,这对于改善预后至关重要。在人类乳腺癌中,IL12A和细胞毒性效应分子的表达预示着对紫杉醇的病理完全缓解率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号